DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,715,178
-29.8%
166,203
-27.7%
0.01%
-33.3%
Q4 2022$6,719,129
-10.9%
229,871
-19.5%
0.01%
-14.3%
Q3 2022$7,545,000
-42.2%
285,611
-2.9%
0.01%
-41.7%
Q2 2022$13,062,000
+54.3%
293,994
+71.8%
0.02%
+84.6%
Q1 2022$8,467,000
+3012.9%
171,096
+3112.5%
0.01%
Q4 2021$272,000
-8.4%
5,3260.0%0.00%
Q3 2021$297,000
+48.5%
5,326
+22.4%
0.00%
-100.0%
Q1 2020$200,000
-0.5%
4,352
+29.9%
0.00%0.0%
Q4 2019$201,000
-18.3%
3,349
-23.0%
0.00%0.0%
Q3 2019$246,000
-95.7%
4,352
-95.8%
0.00%
-94.4%
Q2 2019$5,738,000
+7.6%
103,068
-2.4%
0.02%
+5.9%
Q1 2019$5,331,000
+36.7%
105,598
+6.2%
0.02%
+13.3%
Q4 2018$3,901,000
-50.2%
99,458
-12.0%
0.02%
-46.4%
Q3 2018$7,831,000
-15.5%
112,957
-7.7%
0.03%
-17.6%
Q2 2018$9,263,000
+44.2%
122,434
+0.4%
0.03%
+36.0%
Q1 2018$6,423,000
+29.7%
121,913
+31.4%
0.02%
+31.6%
Q4 2017$4,954,000
-7.3%
92,747
+3.4%
0.02%
-13.6%
Q3 2017$5,347,00089,6610.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders